Immunic AG

Germany


Create a watch for Immunic AG
Total IP 54
Total IP Rank # 25,967
IP Activity Score 2.7/5.0    58
IP Activity Rank # 12,276
Dominant Nice Class Pharmaceutical, veterinary and s...

Patents

Trademarks

19 3
9 1
17 4
1
 
Last Patent 2025 - New deuterated rorgamma/rorgamma...
First Patent 2002 - Compounds as anti-inflammatory, ...
Last Trademark 2025 - VIDO
First Trademark 2020 - Immunic Therapeutics

Industry (Nice Classification)

Latest Inventions, Goods, Services

2025 G/S Pharmaceutical preparations. Pharmaceutical research and development.
G/S Pharmaceutical preparations Pharmaceutical research and development
2024 Invention Treatment of multiple schlerosis comprising dhodh inhibitors. Methods of treating or amelioratin...
Invention Oral pharmaceutical dosage form providing immediate release of vidofludimus. in vitro in vitro co...
Invention Oral pharmaceutical dosage form providing immediate release of vidofludimus. in vitroin vitro con...
Invention Heteroaromatic dhodh inhibitors. The present relates to novel dihydroorotate dehydrogenase (DHODH...
Invention Deuterated analogs of sirtuin 6 modulator imu-856. The present disclosure relates to novel deuter...
Invention Calcium salt polymorphs as anti-inflammatory, immunodulatory and anti-proliferative agents. Subj...
Invention Treatment of inflammatory conditions comprising imu-856. The present invention relates to the sir...
Invention Vidofludimus and related structures acting as nurr1 agonists. The present invention relates to me...
Invention Vidofludimus and related structures acting as nurr1 agonists. The present invention relates to m...
2023 Invention Compounds and dosage regimen for use in the prevention or treatment of chronic inflammatory and/o...
Invention Treatment of multiple sclerosis comprising dhodh inhibitors. Methods of treating or ameliorating ...
Invention Treatment of ulcerative colitis comprising vidofludimus or a pharmaceutically acceptable salt the...
Invention Rorg/rorgt modulators for the treatment of virus infections like covid-19. The present invention ...
Invention New deuterated rorgamma/rorgammat inverse agonists. The invention relates to novel deuterated co...
Invention Deuterated rorgamma/rorgammat inverse agonists. The application relates to isoxazolyl-pyrazole de...
2022 Invention Dhodh inhibitors containing a carboxylic acid bioisostere. The invention relates to novel, optio...
Invention Dhodh inhibitors containing a carboxylic acid bioisostere. The invention relates to novel, option...
Invention Medical use of n4-hydroxy citicoline compounds. The present disclosure relates to the medical us...
Invention Medical use of n4-hydroxy citicoline compounds. The present disclosure relates to the medical use...
Invention Methods for treating cancer. The present invention provides methods comprising one or compounds ...
Invention Methods for treating cancer. The present invention provides methods comprising one or compounds a...
Invention Vidofludimus for use in the treatment or prevention of viral diseases. The present invention rela...
Invention Deuterated dhodh inhibitors. The invention relates to novel deuterated compounds of Formula (I) ...
Invention Deuterated dhodh inhibitors. The invention relates to novel deuterated compounds of Formula (I) a...
2021 G/S Pharmaceutical preparations for the treatment of chronic inflammatory diseases; Pharmaceutical pr...
G/S Pharmaceutical drugs; pharmaceutical preparations; Immunomodulators; pharmaceutical preparations...
2020 G/S Pharmaceutical drugs; Pharmaceutical preparations; Immunomodulators; Pharmaceutical preparations ...
2019 Invention Calcium salt polymorphs as anti-inflammatory, immunomodulatory and anti-proliferative agents. Sub...
Invention Novel calcium salt polymorphs as anti-inflammatory, immunomodulatory and anti-proliferatory agent...
2018 Invention Dosage regimen of vidofludimus for use in the prevention or treatment of chronic inflammatory and...
Invention Il-17 and ifn-gamma inhibition for the treatment of autoimmune diseases and chronic inflammation....
Invention 1-(4-(isoxazol-5-yl)-1h-pyrazol-1-yl)-2-methylpropan-2-ol derivatives and related compounds as il...
2012 Invention Il17 and ifn-gamma inhibition for the treatment of autoimmune inflammation. The present invention...
2011 Invention Calcium salts of compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents. ...
2006 Invention Compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents. The present inven...
2004 Invention Method of identifying inhibitors of dhodh. The present invention provides a compound capable of b...